These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17910915)

  • 1. Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides.
    Urbahns K; Härter M; Albers M; Schmidt D; Stelte-Ludwig B; Brüggemeier U; Vaupel A; Keldenich J; Lustig K; Tsujishita H; Gerdes C
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6151-4. PubMed ID: 17910915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphenyls as potent vitronectin receptor antagonists.
    Urbahns K; Härter M; Albers M; Schmidt D; Stelte-Ludwig B; Brüggemeier U; Vaupel A; Gerdes C
    Bioorg Med Chem Lett; 2002 Jan; 12(2):205-8. PubMed ID: 11755355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
    Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
    Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel potent and selective alphavbeta3/alphavbeta5 integrin dual antagonists with reduced binding affinity for human serum albumin.
    Raboisson P; Manthey CL; Chaikin M; Lattanze J; Crysler C; Leonard K; Pan W; Tomczuk BE; Marugán JJ
    Eur J Med Chem; 2006 Jul; 41(7):847-61. PubMed ID: 16697080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and initial evaluation of novel, non-peptidic antagonists of the alpha(v)-integrins alpha(v)beta(3) and alpha(v)beta(5).
    Letourneau JJ; Liu J; Ohlmeyer MH; Riviello C; Rong Y; Li H; Appell KC; Bansal S; Jacob B; Wong A; Webb ML
    Bioorg Med Chem Lett; 2009 Jan; 19(2):352-5. PubMed ID: 19081719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAR of biphenyl carboxamide ligands of the human melanin-concentrating hormone receptor 1 (MCH R1): discovery of antagonist SB-568849.
    Witty DR; Bateson JH; Hervieu GJ; Jeffrey P; Johnson CN; Muir AI; O'Hanlon PJ; Stemp G; Stevens AJ; Thewlis KM; Wilson S; Winborn KY
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4865-71. PubMed ID: 16839761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclobutane derivatives as potent NK1 selective antagonists.
    Wrobleski ML; Reichard GA; Paliwal S; Shah S; Tsui HC; Duffy RA; Lachowicz JE; Morgan CA; Varty GB; Shih NY
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3859-63. PubMed ID: 16682196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergent, parallel synthesis of a series of beta-substituted 1,2,4-oxadiazole butanoic acids as potent and selective alpha(v)beta3 receptor antagonists.
    Boys ML; Schretzman LA; Chandrakumar NS; Tollefson MB; Mohler SB; Downs VL; Penning TD; Russell MA; Wendt JA; Chen BB; Stenmark HG; Wu H; Spangler DP; Clare M; Desai BN; Khanna IK; Nguyen MN; Duffin T; Engleman VW; Finn MB; Freeman SK; Hanneke ML; Keene JL; Klover JA; Nickols GA; Nickols MA; Steininger CN; Westlin M; Westlin W; Yu YX; Wang Y; Dalton CR; Norring SA
    Bioorg Med Chem Lett; 2006 Feb; 16(4):839-44. PubMed ID: 16298127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849.
    Witty DR; Bateson J; Hervieu GJ; Al-Barazanji K; Jeffrey P; Hamprecht D; Haynes A; Johnson CN; Muir AI; O'Hanlon PJ; Stemp G; Stevens AJ; Thewlis K; Winborn KY
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4872-8. PubMed ID: 16839763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties.
    Tevyashova A; Sztaricskai F; Batta G; Herczegh P; Jeney A
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4783-9. PubMed ID: 15324908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphenyls as potent vitronectin receptor antagonists. Part 2: biphenylalanine ureas.
    Urbahns K; Härter M; Vaupel A; Albers M; Schmidt D; Brüggemeier U; Stelte-Ludwig B; Gerdes C; Tsujishita H
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1071-4. PubMed ID: 12643914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
    Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
    Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [First atomic view of alpha V beta 3 integrin extracellular domain].
    Takagi J
    Tanpakushitsu Kakusan Koso; 2002 Feb; 47(2):153-9. PubMed ID: 11840679
    [No Abstract]   [Full Text] [Related]  

  • 14. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides.
    Fattori D; Rossi C; Fincham CI; Berettoni M; Calvani F; Catrambone F; Felicetti P; Gensini M; Terracciano R; Altamura M; Bressan A; Giuliani S; Maggi CA; Meini S; Valenti C; Quartara L
    J Med Chem; 2006 Jun; 49(12):3602-13. PubMed ID: 16759102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.
    Burch JD; Belley M; Fortin R; Deschênes D; Girard M; Colucci J; Farand J; Therien AG; Mathieu MC; Denis D; Vigneault E; Lévesque JF; Gagné S; Wrona M; Xu D; Clark P; Rowland S; Han Y
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2048-54. PubMed ID: 18291643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists.
    Lai G; Merritt JR; He Z; Feng D; Chao J; Czarniecki MF; Rokosz LL; Stauffer TM; Rindgen D; Taveras AG
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1864-8. PubMed ID: 18304809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV.
    Nakajima Y; Imanishi M; Itou S; Hamashima H; Tomishima Y; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Hattori K
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5037-40. PubMed ID: 18752946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode.
    Angell RM; Bamborough P; Cleasby A; Cockerill SG; Jones KL; Mooney CJ; Somers DO; Walker AL
    Bioorg Med Chem Lett; 2008 Jan; 18(1):318-23. PubMed ID: 18006306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist.
    Lund BW; Piu F; Gauthier NK; Eeg A; Currier E; Sherbukhin V; Brann MR; Hacksell U; Olsson R
    J Med Chem; 2005 Dec; 48(24):7517-9. PubMed ID: 16302793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2).
    Lovering F; Kirincich S; Wang W; Combs K; Resnick L; Sabalski JE; Butera J; Liu J; Parris K; Telliez JB
    Bioorg Med Chem; 2009 May; 17(9):3342-51. PubMed ID: 19364658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.